Recent research from UC San Francisco suggests that the ketogenic diet may offer a new approach to treating multiple sclerosis (MS) and other autoimmune disorders. The study, published in Cell Reports, reveals that the diet promotes the production of two key factors in the gut that alleviated MS symptoms in mice.
The ketogenic diet, which restricts carbohydrates and emphasizes high fat intake, forces the body to burn fat for fuel, producing compounds called ketone bodies. One particular ketone body, β-hydroxybutyrate (βHB), was found to reduce the severity of MS in mice models. Additionally, βHB stimulated the gut bacterium Lactobacillus murinus to produce indole lactic acid (ILA), which inhibited the activation of T helper 17 immune cells associated with MS.
"What was really exciting was finding that we could protect these mice from inflammatory disease just by putting them on a diet that we supplemented with these compounds," said Peter Turnbaugh, senior author of the study.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
The researchers discovered that mice unable to produce βHB in their intestines experienced more severe inflammation. However, supplementing their diets with βHB improved their condition. Further investigation revealed that the beneficial effects of the diet were primarily due to L. murinus and its production of ILA.
While these findings are promising, Turnbaugh cautions that the supplement approach still needs to be tested in humans with autoimmune disorders. He states, "The big question now is how much of this will translate into actual patients. But I think these results provide hope for the development of a more tolerable alternative to helping those people than asking them stick to a challenging restrictive diet".